In another gastric cancer study, RUNX2 was found to promote metastasis through the upregulation of COL1A1 expression, with patients displaying elevated levels of both RUNX2 and COL1A1 experiencing reduced survival times, thereby indicating a poor prognosis [111]. This evidence concerns the gene COL1A1 and gastric cancer.